Ana Belén Crujeiras se alza con el Premio Jesús Serra por su trabajo sobre la progresión del cáncer de mama en mujeres con obesidad

El proyecto hará seguimiento a mujeres posmenopáusicas con obesidad, con y sin cáncer de mama, que adoptarán una dieta cetogénica baja en calorías

El IDIS recibe seis de las ayudas a la investigación de la AECC

La spin-off del IDIS, DIVERSA Technologies, obtuvo la ayuda de mayor cuantía para el desarrollo de nuevas nanoinmunoterapias dirigidas al cáncer gástrico

Un estudio internacional co-liderado por el IDIS y el CiMUS de la USC subraya el valor clínico de las tomografías PET de tau para el diagnóstico y pronóstico del Alzheimer

A raíz de estudio, se llevará a cabo un nuevo ensayo clínico en el Complejo Hospitalario Universitario de Santiago de Compostela (CHUS) enfocado a extender el uso del PET tau a otras enfermedades neurodegenerativas

Research projects
IFUNDANET

News

Calendar

COMMON SUPPORT PLATFORMS

The platforms are research support units featured by a high strategic value, equipped by cutting edge technologies and operated by highly specialised technical staff.

CALLS

All updated information on public and private competitive calls. The most convenient and safest way to send your requests.

CAREERS

Would you like to join our team? We are always looking for people with a passion for research and propelled by insatiable curiosity to join our mission of providing a better healthcare day every day. Here you can see and apply for our current vacancies.

Research Areas

ONCOLOGY

Improvement of treatments: personalised therapy and reduction of side effects.

GENETICS AND SYSTEMS BIOLOGY

Identification of genetic biomarkers of disease susceptibility and prognosis

ENDOCRINOLOGÍA, NUTRICIÓN Y METABOLISMO

The area studies obesity from different perspectives with the participation of groups from the clinical and basic fields in a synergistic way.

NEUROSCIENCES

Search for new therapeutic targets and improvement of the clinical-therapeutic management of neurological patients, mainly stroke, Alzheimer’s, Parkinson’s disease, headaches and neurological diseases caused by prions.

CARDIOVASCULAR

The general objective of the Cardiovascular Area consists of the search for new therapeutic targets and the improvement of clinical-therapeutic management.

PLATFORMS AND METODOLOGY

The area aims at providing evidence for prioritising the management of public resources, evaluating risks and identifying opportunities for improving the health of the population. From here, prioritise structural investments and action programs.

INFECTOLOGY, INFLAMMATION AND VACCINES

Portada ENG

José Ramón González Juanatey

Area Leader A006 - Cardiovascular. Lead Researcher of group C016 - Cardiology

Portada ENG

José Luis Labandeira García

Area Leader A004 - Neurosciences. Lead researcher of group C018 - Experimental Neurology of Parkinson's Disease

Portada ENG

Miguel Ángel Martínez Olmos

Leader Area A003 - Endocrinology, nutrition and metabolism. Leader of group C006 - Molecular endocrinology

Portada ENG

Federico Martinón Torres

Area Leader A007 - Infectology, Inflammation and Vaccines. Lead researcher of the group C020 - Genetics, Vaccines, Infections and Paedriatics (GENVIP)

Portada ENG

Rafael López López

Area Leader A001 - Oncology. Lead Researcher of the group C030 - Translational Medical Oncology

Portada ENG

M. Luz Couce Pico

Scientific Director of the IDIS - Lead Researcher of group C012 - Metabolic Disorders

Portada ENG

Francisco Gude Sampedro

Area Leader A005 - Platforms and Methodology. Lead Researcher of group C015 - Research Methodology

Portada ENG

Angel Carracedo Alvarez

Area leader A002 - Genetics and Systems Biology. Lead Researcher of the group C002 - Genetics

Privacy overview

This website uses cookies so that we can offer you the best possible user experience. The cookie information is stored in your browser and performs functions such as recognizing you when you return to our website or helping our team to understand which sections of the website you find most interesting and useful.